Leverkusen, August 3, 2020 – Bayer has completed the sale of its Animal Health business unit to U.S. company Elanco Animal Health Incorporated. The companies had signed an agreement to this effect in August of last year. The transaction was completed after fulfillment of the closing conditions, including the receipt of regulatory approvals.

Company will make a total payment of $10.1 billion to $10.9 billion (EUR 9.1 billion to EUR 9.8 billion) to resolve current and address potential future Roundup™ litigation / Company also resolves dicamba drift litigation for payment of up to $400 million and most PCB water litigation exposure for payment of approximately $820 million / Funding sourced from free cash flow and Animal Health divestment / Bayer is well positioned to deliver science-based solutions to meet global health, nutrition needs

• Through its new “Better Farms, Better Lives” initiative, Bayer will complement its current commitment to support smallholder farmers in key countries by donating seeds and crop protection inputs
• The donations help boost food security by supporting up to two million smallholder farmers facing increased challenges as a result of the on-going COVID-19 pandemic

Monheim, Germany, 3 June, 2020 – Bayer Animal Health is boosting its solution offerings for shrimp and other warm-water aquaculture species through supply and distribution agreements with water treatment technology suppliers, Cytozyme Laboratories Inc. (“Cytozyme”) and Chengdu Kehongda Technology Co., Ltd (“KEHONDA”), as well as farm management technology provider, XpertSea Solutions Inc (“XpertSea”). 

Leverkusen, March 18, 2020 – Bayer is supporting hospitals in Lombardy, Italy, with a donation of one million euros. The money is being added to an aid fund that the regional authorities in Lombardy have set up to help procure urgently needed equipment for intensive care units in hospitals with the greatest needs. “Our colleagues in Italy are working with unbelievable commitment to maintain the supply of our medicines. On top of that, our emergency aid is designed to help support hospitals and hospital staff during the crisis,” says Werner Baumann, Chairman of the Board of Management of Bayer AG.

Leverkusen, February 26, 2020 – Prof. Dr. Norbert Winkeljohann, 62, is to become Chairman of the Supervisory Board of Bayer AG. As decided at today’s Supervisory Board meeting, Winkeljohann will succeed Werner Wenning, 73, who is to step down with effect from the end of the Annual Stockholders’ Meeting on April 28, 2020.

Monheim, Germany, February 13, 2020 – Bayer announced today pipeline project advancements and newly unveiled research in a dedicated research and development (R&D) pipeline update for the Crop Science Division.

Leverkusen, 28 January, 2020 – Bayer is donating medicines and additional financial aid worth a total of approximately EUR 1.5 million to support the population affected by the outbreak of the novel coronavirus in China.

Monheim/Whippany, N.J., January 31, 2020 – Bayer said today that the U.S. Environmental Protection Agency’s favorable conclusion about the safety of glyphosate in its Interim Registration Review Decision, based on the agency’s expert review over a 10-year period, reaffirms that the extensive body of science continues to support the safety of herbicides containing glyphosate and that this active ingredient is not carcinogenic.

Leverkusen, December 10, 2019 – Bayer has today announced a set of comprehensive sustainability measures and new commitments from 2020 onward.